Periodontal status and hyperlipidemia: Statin users versus non-users

Journal of Periodontology

Volumn 84, Issue 1, 2013, Pages 3-12

  Sangwan, Aditi ^a   Tewari, Shikha ^a   Singh, Harpreet ^b   Sharma, Rajinder K ^a   Narula, Satish C ^a  

^a Government Dental College   (India)

^b POST GRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Cholesterol; Dental scaling; Hydroxymethylglutaryl CoA reductase inhibitors; Hyperlipidemia; Periodontitis

Indexed keywords

ATORVASTATIN; CHOLESTEROL; HEPTANOIC ACID DERIVATIVE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; HYPOCHOLESTEROLEMIC AGENT; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PYRROLE DERIVATIVE; TRIACYLGLYCEROL;

ADULT; ARTICLE; BLOOD; CHRONIC PERIODONTITIS; CLASSIFICATION; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; DRUG EFFECT; FEMALE; HUMAN; HYPERLIPIDEMIA; MALE; PERIODONTAL DISEASE; PERIODONTAL POCKET; PERIODONTICS; PERIODONTIUM; SINGLE BLIND PROCEDURE; TOOTH PLAQUE;

ADULT; ANTICHOLESTEREMIC AGENTS; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CHRONIC PERIODONTITIS; CROSS-SECTIONAL STUDIES; DENTAL PLAQUE INDEX; FEMALE; HEPTANOIC ACIDS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERLIPIDEMIAS; MALE; PERIODONTAL ATTACHMENT LOSS; PERIODONTAL INDEX; PERIODONTAL POCKET; PERIODONTIUM; PYRROLES; SINGLE-BLIND METHOD; TRIGLYCERIDES;

EID: 84872012552     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2012.110756     Document Type: Article

References (49)

1. Nibali L, D'Aiuto F, Griffiths G, Patel K, Suvan J, Tonetti MS. Severe periodontitis is associated with systemic inflammation and a dysmetabolic status: A case-control study. J Clin Periodontol 2007;34:931-937.
2. Kim J, Amar S. Periodontal disease and systemic conditions: A bidirectional relationship. Odontology 2006;94:10-21.
3. Davé S, Van Dyke T. The link between periodontal disease and cardiovascular disease is probably inflammation. Oral Dis 2008;14:95-101.
4. Castelli WP. Lipids, risk factors and ischaemic heart disease. Atherosclerosis 1996;124(Suppl.):S1-S9.
5. Stapleton PA, Goodwill AG, James ME, Brock RW, Frisbee JC. Hypercholesterolemia and microvascular dysfunction: Interventional strategies. J Inflamm (Lond) 2010;7:54.
6. Niemann-Jönsson A, Dimayuga P, Jovinge S, et al. Accumulation of LDL in rat arteries is associated with activation of tumor necrosis factor-alpha expression. Arterioscler Thromb Vasc Biol 2000;20:2205-2211.
7. Thomas CE, Jackson RL, Ohlweiler DF, Ku G. Multiple lipid oxidation products in low density lipoproteins induce interleukin-1 beta release from human blood mononuclear cells. J Lipid Res 1994;35:417-427.
8. Chu X, Newman J, Park B, Nares S, Ordonez G, Iacopino AM. In vitro alteration of macrophage phenotype and function by serum lipids. Cell Tissue Res 1999;296:331-337.
9. Heasman PA, Collins JG, Offenbacher S. Changes in crevicular fluid levels of interleukin-1 beta, leukotriene B4, prostaglandin E2, thromboxane B2 and tumour necrosis factor alpha in experimental gingivitis in humans. J Periodontal Res 1993;28:241-247.
10. Pohl A, Pohl C, Krause S, Gangler P, Losche W. Hyperlipidemia, atherosclerosis, and oral inflammatory diseases. Acta Angiologica 1995;1:133-137.
11. Cutler CW, Shinedling EA, Nunn M, et al. Association between periodontitis and hyperlipidemia: Cause or effect? J Periodontol 1999;70:1429-1434.
12. Noack B, Jachmann I, Roscher S, et al. Metabolic diseases and their possible link to risk indicators of periodontitis. J Periodontol 2000;71:898-903.
13. Lösche W, Karapetow F, Pohl A, Pohl C, Kocher T. Plasma lipid and blood glucose levels in patients with destructive periodontal disease. J Clin Periodontol 2000;27:537-541.
14. Katz J, Flugelman MY, Goldberg A, Heft M. Association between periodontal pockets and elevated cholesterol and low density lipoprotein cholesterol levels. J Periodontol 2002;73:494-500.
15. Morita M, Horiuchi M, Kinoshita Y, Yamamoto T, Watanabe T. Relationship between blood triglyceride levels and periodontal status. Community Dent Health 2004;21:32-36.
16. Moeintaghavi A, Haerian-Ardakani A, Talebi-Ardakani M, Tabatabaie I. Hyperlipidemia in patients with periodontitis. J Contemp Dent Pract 2005;6:78-85.
17. Monteiro AM, Jardini MA, Alves S, et al. Cardiovascular disease parameters in periodontitis. J Periodontol 2009; 80:378-388.
18. Fentoǧlu O, Oz G, Tasxdelen P, Uskun E, Aykacx Y, Bozkurt FY. Periodontal status in subjects with hyperlipidemia. J Periodontol 2009;80:267-273.
19. Ramirez-Tortosa MC, Quiles JL, Battino M, et al. Periodontitis is associated with altered plasma fatty acids and cardiovascular risk markers. Nutr Metab Cardiovasc Dis 2010;20:133-139.
20. Taleghani F, Shamaei M, Shamaei M. Association between chronic periodontitis and serum lipid levels. Acta Med Iran 2010;48:47-50.
21. Awartani F, Atassi F. Evaluation of periodontal status in subjects with hyperlipidemia. J Contemp Dent Pract 2010;11:33-40.
22. Fentoǧlu Ö, Köroǧlu BK, Hicxyilmaz H, et al. Proinflammatory cytokine levels in association between periodontal disease and hyperlipidaemia. J Clin Periodontol 2011;38:8-16.
23. Fentoǧlu O, Köroǧlu BK, Kara Y, et al. Serum lipoprotein-associated phospholipase A2 and C-reactive protein levels in association with periodontal disease and hyperlipidemia. J Periodontol 2011;82:350-359.
24. Machado AC, Quirino MR, Nascimento LF. Relation between chronic periodontal disease and plasmatic levels of triglycerides, total cholesterol and fractions. Braz Oral Res 2005;19:284-289.
25. Valentaviciene G, Paipaliene P, Nedzelskiene I, Zilinskas J, Anuseviciene OV. The relationship between blood serum lipids and periodontal condition. Stomatologija 2006;8:96-100.
26. Korhonen S, Saxlin T, Suominen L, Jula A, Knuuttila M, Ylöstalo P. Serum cholesterol ratios and periodontal infection: Results of the Health 2000 Survey. J Clin Periodontol 2011;38:787-794.
27. McCarey DW, McInnes IB, Madhok R, et al. Trial of Atorvastatin in Rheumatoid Arthritis (TARA): Doubleblind, randomised placebo-controlled trial. Lancet 2004;363:2015-2021.
28. Vieira JM Jr., Mantovani E, Rodrigues LT, et al. Simvastatin attenuates renal inflammation, tubular transdifferentiation and interstitial fibrosis in rats with unilateral ureteral obstruction. Nephrol Dial Transplant 2005;20:1582-1591.
29. Mira E, Man?es S. Immunomodulatory and anti-inflammatory activities of statins. Endocr Metab Immune Disord Drug Targets 2009;9:237-247.
30. Yazawa H, Zimmermann B, Asami Y, Bernimoulin JP. Simvastatin promotes cell metabolism, proliferation, and osteoblastic differentiation in human periodontal ligament cells. J Periodontol 2005;76:295-302.
31. Sakoda K, Yamamoto M, Negishi Y, Liao JK, Node K, Izumi Y. Simvastatin decreases IL-6 and IL-8 production in epithelial cells. J Dent Res 2006;85:520-523.
32. Vaziri H, Naserhojjati-Roodsari R, Tahsili-Fahadan N, et al. Effect of simvastatin administration on periodontitis-associated bone loss in ovariectomized rats. J Periodontol 2007;78:1561-1567.
33. Jeon JH, Piepgrass WT, Lin YL, Thomas MV, Puleo DA. Localized intermittent delivery of simvastatin hydroxyacid stimulates bone formation in rats. J Periodontol 2008;79:1457-1464.
34. Seto H, Ohba H, Tokunaga K, Hama H, Horibe M, Nagata T. Topical administration of simvastatin recovers alveolar bone loss in rats. J Periodontal Res 2008;43:261-267.
35. Cunha-Cruz J, Saver B, Maupome G, Hujoel PP. Statin use and tooth loss in chronic periodontitis patients. J Periodontol 2006;77:1061-1066.
36. Lindy O, Suomalainen K, Mäkelä M, Lindy S. Statin use is associated with fewer periodontal lesions: A retrospective study. BMC Oral Health 2008;8:16.
37. Saxlin T, Suominen-Taipale L, Knuuttila M, Alha P, Ylöstalo P. Dual effect of statin medication on the periodontium. J Clin Periodontol 2009;36:997-1003.
38. Silness J, Löe H. Periodontal disease in pregnancy. II. Correlation between oral hygiene and periodontal condition. Acta Odontol Scand 1964;22:121-135.
39. Löe H, Silness J. Periodontal disease in pregnancy. I. Prevalence and severity. Acta Odontol Scand 1963;21: 533-551.
40. Saver BG, Hujoel PP, Cunha-Cruz J, Maupomé G. Are statins associated with decreased tooth loss in chronic periodontitis? J Clin Periodontol 2007;34: 214-219.
41. Imrey PB. Considerations in the statistical analysis of clinical trials in periodontitis. J Clin Periodontol 1986; 13:517-532.
42. Farah R, Shurtz-Swirski R, Dorlechter F. Primed polymorphonuclear leukocytes constitute a possible link between inflammation and oxidative stress in hyperlipidemic patients: Effect of statins. Minerva Cardioangiol 2010;58:175-181.
43. Montecucco F, Bertolotto M, Ottonello L, et al. Chlorhexidine prevents hypochlorous acid-induced inactivation of alpha1-antitrypsin. Clin Exp Pharmacol Physiol 2009;36:e72-e77.
44. Scardina GA, Pisano T, Cacioppo A, Messina P. Periodontal alteration of the microcirculation and hypercholesterolemia: A possible correlation? South Med J 2011; 104:116-120.
45. Luan Z, Chase AJ, Newby AC. Statins inhibit secretion of metalloproteinases-1, -2, -3, and -9 from vascular smooth muscle cells and macrophages. Arterioscler Thromb Vasc Biol 2003;23:769-775.
46. Koh KK, Son JW, Ahn JY, et al. Comparative effects of diet and statin on NO bioactivity and matrix metalloproteinases in hypercholesterolemic patients with coronary artery disease. Arterioscler Thromb Vasc Biol 2002;22:e19-e23.
47. Yang H, Feng Y, Luan Y. Determination of Simvastatin in human plasma by liquid chromatography-mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2003;785:369-375.
48. Fajardo ME, Rocha ML, Sánchez-Marin FJ, Espinosa- Chávez EJ. Effect of atorvastatin on chronic periodontitis: A randomized pilot study. J Clin Periodontol 2010;37:1016-1022.
49. Hujoel PP, Drangsholt M, Spiekerman C, DeRouen TA. Periodontitis-systemic disease associations in the presence of smoking - Causal or coincidentald? Periodontol 2000 2002;30:51-60.